COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,710 Articles (22,913 medRxiv, 8,797 bioRxiv)

Most recent first Previous |  Page 1223: Articles 12221-12230  | Next

A cohort of 222 anti-CD20 treated patients with multiple sclerosis followed through the COVID-19 pandemic: Attenuated humoral but robust cellular immune responses after vaccination and infection
Schwarz, T., Otto, C., Jones, T. C., Pache, F., Schindler, P., Niederschweiberer, M., Schmidt, F., Drosten, C., Corman, V. M., Ruprecht, K.
10.1101/2021.10.11.21264694 — Posted: 2021-10-19
Mapping Molecular Gene Signatures Among Respiratory Viruses Based on Large-Scale and Genome-wide Transcriptomics Analysis
Smith, T., Rohaim, M. A., Munir, M.
10.1101/2021.10.17.464720 — Posted: 2021-10-18
Plant-based production of SARS-CoV-2 antigens for use in a subunit vaccine
Demone, J. J., Maltseva, M., Nourimand, M., Nasr-Sharif, M., Galipeau, Y., Langlois, M.-A., MacLean, A. M.
10.1101/2021.10.17.464700 — Posted: 2021-10-18
Bees can be trained to identify SARS-CoV-2 infected samples.
Kontos, E., Samimi, A., Hakze-van der Honing, R. W., Priem, J., Avargues-Weber, A., Haverkamp, A., Dicke, M., Gonzales, J., van der Poel, W. H.
10.1101/2021.10.18.464814 — Posted: 2021-10-18 Discussion: Onsite
Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine
Peng, K. W., Carey, T., Lech, P., Vandergaast, R., Munoz-Alia, M. A., Packiriswamy, N., Gnanadurai, C., Krotova, K., Tesfay, M., Ziegler, C., Haselton, M., Sevola, K., Lathrum, C., Reiter, S., Narjari, R., Balakrishnan, B., Suksanpaisan, L., Sakuma, T., Recker, J., Zhang, L., Waniger, S., Russell, L., Petro, C., Kyratsous, C. A., Baum, A., Janecek, J. L., Lee, R., Ramachandran, S., Graham, M., Russell, S. J.
10.1101/2021.10.16.464660 — Posted: 2021-10-18
Long-term manifestations and modifiers of prevalence estimates of the post-COVID-19 syndrome: A systematic review and meta-analysis.
De-la-Rosa-Martinez, D., Delaye-Martinez, M. A., Bello-Chavolla, O. Y., Sicilia-Andrade, A., Juarez-Cruz, I. D., Fermin-Martinez, C. A., Marquez-Salinas, A., C. Guerra, E., Fernandez-Chirino, L., Martinez-Gutierrez, M. I., Sandoval-Colin, D. E., Vilar-Compte, D.
10.1101/2021.10.17.21265123 — Posted: 2021-10-18
Mitoxantrone modulates a glycosaminoglycan-spike complex to inhibit SARS-CoV-2 infection
Zhang, Q., Radvak, P., Lee, J., Xu, Y., Cao-Dao, V., Xu, M., Zheng, W., Chen, C. Z., Xie, H., Ye, Y.
10.1101/2021.10.15.464595 — Posted: 2021-10-18
Reductions in US life expectancy from COVID-19 by Race and Ethnicity: Is 2021 a repetition of 2020?
Andrasfay, T., Goldman, N.
10.1101/2021.10.17.21265117 — Posted: 2021-10-18
Comparative assessment of methods for short-term forecasts of COVID-19 admissions in England at the local level
Meakin, S., Abbott, S., Bosse, N. I., Munday, J. D., Gruson, H., Hellewell, J., Sherratt, K., CMMID COVID-19 Working Group, , Funk, S.
10.1101/2021.10.18.21265046 — Posted: 2021-10-18
Time-varying effectiveness of the mRNA-1273, BNT162b2 and Ad26.COV2.S vaccines against SARS-CoV-2 infections and COVID-19 hospitalizations and deaths: an analysis based on observational data from Puerto Rico
Robles-Fontan, M. M., Nieves, E. G., Cardona-Gerena, I., Irizarry, R. A.
10.1101/2021.10.17.21265101 — Posted: 2021-10-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).